Clinical Trials and Research News Weekly Roundup | S2 E24

Ivermectin Peru

Peru. A place that appears to be the epicenter of the movement for off-label use of #Ivermectin to treat #COVID-19 patients. The doctors there swear by it. In fact, some of them curse the government for not embracing the anti-parasite drug sooner as they believe more lives could have been saved. With the advent of the COVID-19 pandemic, the Peruvian authorities had no interest in Ivermectin. Rather, they leaned toward the emerging standard of care that was circulated in medical circles from the World Health Organization (WHO). However, when a group of Australians at Monash University and Peter Doherty Institute performed lab tests revealing that the economical and available anti-parasitic medicine did indeed zap the novel coronavirus, a local inquiry commenced. This grassroots medical movement for Ivermectin as a treatment for COVID-19 in many ways has been driven out of #Peru as the story continues to unfold.